Home000963 • SHE
Huadong Medicine Co., Ltd.
¥37.62
Apr 25, 4:29:45 PM GMT+8 · CNY · SHE · Disclaimer
StockCN listed security
Previous close
¥39.22
Day range
¥37.11 - ¥38.51
Year range
¥25.96 - ¥40.80
Market cap
65.99B CNY
Avg Volume
15.76M
P/E ratio
18.78
Dividend yield
1.70%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
(CNY)Mar 2025Y/Y change
Revenue
10.74B3.12%
Operating expense
2.33B3.90%
Net income
914.71M6.06%
Net profit margin
8.522.90%
Earnings per share
0.517.06%
EBITDA
1.39B9.15%
Effective tax rate
17.28%
Total assets
Total liabilities
(CNY)Mar 2025Y/Y change
Cash and short-term investments
3.71B4.18%
Total assets
39.45B14.45%
Total liabilities
14.88B24.24%
Total equity
24.56B
Shares outstanding
1.75B
Price to book
2.85
Return on assets
7.79%
Return on capital
11.18%
Net change in cash
(CNY)Mar 2025Y/Y change
Net income
914.71M6.06%
Cash from operations
-832.73M-71.87%
Cash from investing
-645.84M8.70%
Cash from financing
-86.84M-221.46%
Net change in cash
-1.57B-42.20%
Free cash flow
-1.87B-52.41%
About
HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share capital of 380,000,000 renminbi and a market capitalization of 126,323,040 renminbi as of July 2005. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China. Wikipedia
Founded
Mar 31, 1993
Employees
18,265
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu